Literature DB >> 18990703

Poly(ADP-ribose) polymerase-1 down-regulates BRCA2 expression through the BRCA2 promoter.

Jinhua Wang1, Chunjing Bian, Jing Li, Fergus J Couch, Kangjian Wu, Robert Chunhua Zhao.   

Abstract

Expression of the BRCA2 tumor suppressor gene is tightly linked to its roles in DNA damage repair and maintenance of chromosomal stability and genomic integrity. Three transcription factors that activate (USF, NF-kappaB, and Elf1) and a single factor that represses (SLUG) BRCA2 promoter activity have been reported. In addition, a 67-bp region (-582 to -516) associated with inhibition of promoter activity has been identified. However, it remains unclear how the 67-bp region contributes to regulation of BRCA2 expression. Here, we describe the affinity purification of a 120-kDa protein that binds to a silencer-binding region within the 67-bp repression region of the BRCA2 promoter. Mass spectrometry revealed the identity of the protein as poly-(ADP-ribose) polymerase-1 (Parp-1). Gel shift, antibody super-shift, and chromatin immunoprecipitation (ChIP) assays demonstrated that Parp-1 is associated with the BRCA2 promoter both in vitro and in vivo. Furthermore, Parp-1 inhibitors (either 3-AB or NU1025) and Parp-1 gene specific siRNA resulted in increased levels of endogenous BRCA2 expression. Inhibition of Parp-1 activity (by 3-AB) reduced histone 3 lysine 9 acetylation and blocked Parp-1 binding to the BRCA2 promoter. These results indicate that Parp-1 down-regulates BRCA2 expression through an interaction with a repression region of the BRCA2 promoter.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18990703      PMCID: PMC2605989          DOI: 10.1074/jbc.M803693200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Poly(ADP-ribose) polymerase is a B-MYB coactivator.

Authors:  M N Cervellera; A Sala
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

2.  Transcriptional repression by binding of poly(ADP-ribose) polymerase to promoter sequences.

Authors:  Viatcheslav A Soldatenkov; Sergey Chasovskikh; Vladimir N Potaman; Irina Trofimova; Mark E Smulson; Anatoly Dritschilo
Journal:  J Biol Chem       Date:  2001-10-29       Impact factor: 5.157

3.  Isolation and initial characterization of the BRCA2 promoter.

Authors:  P L Davis; A Miron; L M Andersen; J D Iglehart; J R Marks
Journal:  Oncogene       Date:  1999-10-28       Impact factor: 9.867

4.  Poly-(ADP-ribose) polymerase-1 (Parp-1) binds in a sequence-specific manner at the Bcl-6 locus and contributes to the regulation of Bcl-6 transcription.

Authors:  H E Ambrose; V Papadopoulou; R W Beswick; S D Wagner
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

5.  Induction of the BRCA2 promoter by nuclear factor-kappa B.

Authors:  K Wu; S W Jiang; M Thangaraju; G Wu; F J Couch
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

6.  p53 mediates repression of the BRCA2 promoter and down-regulation of BRCA2 mRNA and protein levels in response to DNA damage.

Authors:  Kangjian Wu; Shi-Wen Jiang; Fergus J Couch
Journal:  J Biol Chem       Date:  2003-02-18       Impact factor: 5.157

Review 7.  The PARP superfamily.

Authors:  Jean-Christophe Amé; Catherine Spenlehauer; Gilbert de Murcia
Journal:  Bioessays       Date:  2004-08       Impact factor: 4.345

Review 8.  The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders.

Authors:  P O Hassa; M O Hottiger
Journal:  Cell Mol Life Sci       Date:  2002-09       Impact factor: 9.261

9.  Analysis of nucleotide sequence-dependent DNA binding of poly(ADP-ribose) polymerase in a purified system.

Authors:  Kai Huang; William E Tidyman; Kim-Uyen T Le; Eva Kirsten; Ernest Kun; Charles P Ordahl
Journal:  Biochemistry       Date:  2004-01-13       Impact factor: 3.162

10.  Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci.

Authors:  Alexei Tulin; Allan Spradling
Journal:  Science       Date:  2003-01-24       Impact factor: 47.728

View more
  15 in total

Review 1.  DNA transcription and repair: a confluence.

Authors:  Robb E Moses; Bert W O'Malley
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

2.  14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.

Authors:  Yifan Chen; Zhaomin Li; Zizheng Dong; Jenny Beebe; Ke Yang; Liwu Fu; Jian-Ting Zhang
Journal:  Mol Cancer Res       Date:  2017-01-13       Impact factor: 5.852

Review 3.  Appraising iniparib, the PARP inhibitor that never was--what must we learn?

Authors:  Joaquin Mateo; Michael Ong; David S P Tan; Michael A Gonzalez; Johann S de Bono
Journal:  Nat Rev Clin Oncol       Date:  2013-10-15       Impact factor: 66.675

4.  Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells.

Authors:  Smita Misra; Shvetank Sharma; Anupriya Agarwal; Sheetal V Khedkar; Manish K Tripathi; Mukul K Mittal; Gautam Chaudhuri
Journal:  Mol Cancer       Date:  2010-03-04       Impact factor: 27.401

5.  FASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-κB and SP1.

Authors:  Xi Wu; Zizheng Dong; Chao J Wang; Lincoln James Barlow; Valerie Fako; Moises A Serrano; Yue Zou; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

6.  Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types.

Authors:  Valeria Ossovskaya; Ingrid Chou Koo; Eric P Kaldjian; Christopher Alvares; Barry M Sherman
Journal:  Genes Cancer       Date:  2010-08

Review 7.  Medial Arterial Calcification: A Significant and Independent Contributor of Peripheral Artery Disease.

Authors:  Cynthia St Hilaire
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-01-27       Impact factor: 8.311

8.  Higher cytoplasmic and nuclear poly(ADP-ribose) polymerase expression in familial than in sporadic breast cancer.

Authors:  Marie-Luise Klauke; Nicoline Hoogerbrugge; Jan Budczies; Peter Bult; Judith Prinzler; Cornelia Radke; J Han J M van Krieken; Manfred Dietel; Carsten Denkert; Berit Maria Müller
Journal:  Virchows Arch       Date:  2012-09-12       Impact factor: 4.064

Review 9.  PARP1: Structural insights and pharmacological targets for inhibition.

Authors:  Jacob O Spiegel; Bennett Van Houten; Jacob D Durrant
Journal:  DNA Repair (Amst)       Date:  2021-04-14

10.  Resistance to PARP-Inhibitors in Cancer Therapy.

Authors:  Alicia Montoni; Mihaela Robu; Emilie Pouliot; Girish M Shah
Journal:  Front Pharmacol       Date:  2013-02-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.